Skip to main content
TipRanks
Go Ultimate75% OFF

Neurotech International (NTI) Stock Statistics & Valuation Metrics

11 Followers

Total Valuation

Neurotech International has a market cap or net worth of AUD 32.32M. The enterprise value is AUD 16.06M.

Market Cap
AUD 32.32M
Enterprise Value
AUD 16.06M

Share Statistics

Neurotech International has 1,616,070,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,616,070,000
Owned by Insiders
10.80%
Owned by Institutions
―

Financial Efficiency

Neurotech International’s return on equity (ROE) is -10.70 and return on invested capital (ROIC) is -1075.52%.

Return on Equity (ROE)
-10.70
Return on Assets (ROA)
-2.38
Return on Invested Capital (ROIC)
-1075.52%
Return on Capital Employed (ROCE)
-18.54
Revenue Per Employee
0
Profits Per Employee
-363.25K
Employee Count
18
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Neurotech International is -4.77. Neurotech International’s PEG ratio is 0.54.

PE Ratio
-4.77
PS Ratio
0.00
PB Ratio
45.28
Price to FCF
-8.03
Price to Operating Cash Flow
-6.55
PEG Ratio
0.54

Income Statement

In the last 12 months, Neurotech International had revenue of 0 and earned -6.54M in profits. Earnings per share was -0.01.

Revenue
0
Gross Profit
0
Operating Income
-11.33M
Pretax Income
-11.27M
Net Income
-6.54M
EBITDA
-11.33M
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was -4.22M and capital expenditures -4, giving a free cash flow of -4.22M billion.

Operating Cash Flow
-4.22M
Free Cash Flow
-4.22M
Free Cash Flow per Share
-0.00

Dividends & Yields

Neurotech International pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-13.07%
Earnings Yield
-24.81%

Stock Price Statistics

Beta
0.99
52-Week Price Change
25.00%
50-Day Moving Average
0.01
200-Day Moving Average
0.01
Relative Strength Index (RSI)
71.10
Average Volume (3m)
4.48M

Important Dates

Neurotech International upcoming earnings date is Mar 02, 2027, TBA (Not Confirmed).

Last Earnings Date
Sep 02, 2026
Next Earnings Date
Mar 02, 2027
Ex-Dividend Date
―

Financial Position

Neurotech International as a current ratio of 1.29, with Debt / Equity ratio of 0.00%

Current Ratio
1.29
Quick Ratio
1.29
Debt to Market Cap
0.00
Net Debt to EBITDA
0.21
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Neurotech International has paid -4.73M in taxes.

Income Tax
-4.73M
Effective Tax Rate
0.42

Enterprise Valuation

Neurotech International EV to EBITDA ratio is -2.64, with an EV/FCF ratio of -7.09.

EV to Sales
0.00
EV to EBITDA
-2.64
EV to Free Cash Flow
-7.09
EV to Operating Cash Flow
-7.09

Balance Sheet

Neurotech International has AUD 2.39M in cash and marketable securities with AUD 0.00 in debt, giving a net cash position of AUD 2.39M billion.

Cash & Marketable Securities
AUD 2.39M
Total Debt
AUD 0.00
Net Cash
AUD 2.39M
Net Cash Per Share
AUD 0.00
Tangible Book Value Per Share
AUD 0.00

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Neurotech International is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-100.00%
EPS Growth Forecast
50.49%

Scores

Smart Score
7
AI Score
47